Engaging in physical activity may improve the quality of life for people newly diagnosed with multiple sclerosis, a link that remained even after accounting for other factors such as fatigue and disability status, a study shows.
Patricia Valerio, PhD
Patricia holds a PhD in Neurobiology from the University of Basel, Switzerland, where she studied how hearing develops and functions. She is originally from Portugal and earned an MSc in Cellular and Molecular Biology, focusing on metabolic diseases, such as diabetes, and a BSc in Biomedical Pharmacy from the University of Coimbra. Patricia enjoys communicating science to inspire, educate and help different audiences understand its complexity and relevance.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Valerio, PhD
People with relapsing-remitting multiple sclerosis (RRMS) who report better physical health are significantly more likely to…
Increased activation of microglia, the resident immune cells in the brain that contribute to chronic inflammation in…
An eight-week intermittent fasting intervention for people with relapsing-remitting multiple sclerosis (RRMS)…
A reduction in the levels of an inflammatory molecule called chemokine ligand 13 (CXCL13) may serve as a biomarker of…
Two years of treatment with the approved therapy >Copaxone (glatiramer acetate) was found to slow the…
Individuals with primary progressive multiple sclerosis (PPMS) have significantly higher concentrations of specific inflammation biomarkers in their spinal fluid…
Dosing of NVG-291, NervGen Pharma’s investigational therapy for multiple sclerosis (MS) and other nervous system diseases, was completed…
Worse disability scores in multiple sclerosis (MS) patients with restless legs syndrome (RLS) were significantly associated with the…
An intravenous (into-the-vein) formulation of ofatumumab — a disease-modifying therapy for multiple sclerosis (MS) sold under the brand…
People with progressive forms of multiple sclerosis (MS) are nearly four times more likely to have serious infections —…
The levels of two cerebrospinal fluid (CSF) biomarkers, CHI3L1 and CXCL13, were significantly elevated in people with relapsing and progressive…
High adherence to a Mediterranean diet is associated with a lower risk of disability outcomes, as well as reported disease…
People with relapsing-remitting multiple sclerosis (RRMS) or clinically isolated syndrome (CIS) have lower cholesterol levels in their blood…
Blood levels of nesfatin-1, irisin, adropin, and preptin — all regulatory hormones known to control energy balance — are…
Multiple sclerosis (MS) patients who started taking Tysabri (natalizumab) long after their diagnosis were found to have worsened…
mSteps, a new phone app, could be used to precisely measure the outdoor walking distance of people affected by…